Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Endobronchial Valve Demonstrates Sustained Improvements for Severe Emphysema

Researchers found 'statistically significant improvements' in lung function, respiratory symptoms, and quality of life measures at 24 months.

Chronic Pulmonary Disorders

World COPD Day 2023 Emphasizes Early Detection

On November 15th, healthcare organizations across the globe are observing World COPD Day 2023 by emphasizing the importance of early disease detection.

Chronic Pulmonary Disorders

CVS Pulls Certain Decongestants from Store Shelves

CVS Health is pulling certain oral decongestants from its shelves that contain phenylephrine, an ingredient an FDA panel recently deemed ineffective.

Asthma

HCO Acquires Virtual Care Platform to Expand Respiratory Therapy Services

Health Care Originals, a maker of cardiopulmonary wearable systems, acquired Dawn Health’s virtual sleep care platform to accelerate the deployment of its Nightingale virtual care to benefit Americans with asthma or COPD.

COPD

Suspected Bronchiectasis Tied to Higher Mortality, Even Without COPD

A study of current and former smokers found that suspected bronchiectasis is associated with a heightened risk of all-cause mortality, even without the presence of COPD.

Cystic fibrosis

Disease-causing Stem Cells Dominate Lungs of Advanced CF Patients

Five lung stem cell variants dominate the lungs of patients with advanced cystic fibrosis (CF), and these variants drive key aspects of CF pathology including inflammation, fibrosis, and mucin secretion, according to new research.

Pulmonary Fibrosis

Cleveland Clinic Pulmonologist Takes Helm at Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.

Allergies

Decongestant in Popular OTC Cold and Allergy Meds Doesn’t Work, FDA Panel Says

An FDA advisory committee determined that phenylephrine, common in brands like Benadryl and Mucinex, is ineffective as a nasal decongestant.

Other Chronic Diseases

Idrevloride in Hypertonic Saline Boosts Lung Function in Primary Ciliary Dyskinesia Patients

A new study finds that idrevloride in hypertonic saline is safe and associated with a significant improvement in lung function in individuals with primary ciliary dyskinesia when compared to hypertonic saline alone.